Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Ambalal Sarabhai Enterprises Ltd. Share Price
Day's Range
Day's Range
Low
₹30.67
High
₹31.80
Price Summary
| Previous Close | ₹30.96 |
|---|---|
| Day's Range | ₹30.67 - ₹31.80 |
| Open | ₹31.80 |
| 52 Week Range | ₹30.30 - ₹36.15 |
| Volume | 21,786 |
| Market Cap | ₹0.00 |
| Previous Close | ₹30.80 |
|---|---|
| Day's Range | ₹30.70 - ₹31.46 |
| Open | ₹30.99 |
| 52 Week Range | ₹23.12 - ₹40.44 |
| Volume | 4,062 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 6.74 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 21.52 |
| TTM EPS (₹) | 1.44 |
| P/E Ratio | 54.47 |
| Book Value(₹) | 1.57 |
| PAT Margin (%) | 2.44 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 5.20 |
| Trade Value ( ₹ in Lacs) | 1.25 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 21.52 |
| TTM EPS (₹) | 1.44 |
| P/E Ratio | 54.47 |
| Book Value(₹) | 1.57 |
| PAT Margin (%) | 2.44 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 5.20 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 459.71 | 38.11 |
| Expenses | N/A | N/A |
| PBT | 29.3 | 8.14 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 22.32 | 25.83 |
About Ambalal Sarabhai Enterprises Ltd.
| Founded | 1978 |
|---|---|
| Managing Director | Mohal K Sarabhai |
| NSE Symbol | AMBALALSA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,42,893.24 | 1,824.30 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,76,366.71 | 6,789.10 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,240.79 | 4,325.20 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,15,309.54 | 8,008.45 | 6,696.50 - 6,696.50 |
| Dr. Reddy's Laboratories Ltd. | 1,06,009.78 | 1,273.30 | 1,148.40 - 1,148.40 |
| Cipla Ltd. | 1,04,365.52 | 1,330.35 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,02,690.68 | 2,224.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 99,183.27 | 1,028.00 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 98,147.87 | 2,415.30 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 93,655.23 | 940.00 | 835.50 - 835.50 |
No Records Found
Latest News
Cipla informs about investor presentation
Abbott India informs about notice of postal ballot
Zydus Lifesciences informs about change in director
Pursuant to the provisions of regulation 30 read with clause 7 of para A of part A of Schedule III of the Listing Regulations, Zydus Lifesciences has informed that S. Diwanji (DIN: 00032072) ceased as the Director (including as the Independent Director) effective Tuesday, May 12, 2026, consequent upon completion of his tenure. The Company places on record its sincere appreciation for the valuable contributions made by Diwanji during his tenure. The Company also expressed its gratitude for Diwanji’s dedication, integrity, and professional expertise, which have enriched deliberations and decision-making processes. The requisite details as per the SEBI Master Circular are attached as Annexure – ‘A’.
The above information is a part of company’s filings submitted to BSE.
Park Medi World informs about newspaper advertisement
Neuland Laboratories informs about newspaper advertisement
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Ambalal Sarabhai Enterprises Ltd. is ₹30.96 as of 2026-05-13.
The market capitalisation of Ambalal Sarabhai Enterprises Ltd. is ₹237.41 as of 2026-05-12.
The 1-year return of Ambalal Sarabhai Enterprises Ltd. is 0.05% as of 2026-05-13.
The P/E ratio of Ambalal Sarabhai Enterprises Ltd. is 54.47 as of 2026-05-13.
The 52-week high and low of Ambalal Sarabhai Enterprises Ltd. are ₹36.15 and ₹30.30, respectively, as of 2026-05-13.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
